Filters close
Newswise: Improving Health One Dish at a Time
Released: 10-Jun-2024 11:05 AM EDT
Improving Health One Dish at a Time
Philadelphia College of Osteopathic Medicine

Students in PCOM South Georgia’s culinary medicine course recently traded in their white coats for aprons to study the nutrition and biochemical properties of food while also learning how to prepare nutritious meals.

Newswise: Super-Chilled Brain Cell Molecules Reveal How Epilepsy Drug Works
Released: 10-Jun-2024 11:00 AM EDT
Super-Chilled Brain Cell Molecules Reveal How Epilepsy Drug Works
Johns Hopkins Medicine

By super cooling a molecule on the surface of brain cells down to about minus 180 degrees Celsius — nearly twice as cold as the coldest places in Antarctica — scientists at Johns Hopkins Medicine say they have determined how a widely-used epilepsy drug works to dampen the excitability of brain cells and help to control, although not cure, seizures.

Newswise: New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
5-Jun-2024 11:05 PM EDT
New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
American Cancer Society (ACS)

A new study led by American Cancer Society researchers shows less than one-in-five eligible individuals in the United States were up-to-date with recommended lung cancer screening. The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden.

Newswise: Multicenter clinical study supports safety of deep general anesthesia
5-Jun-2024 3:05 PM EDT
Multicenter clinical study supports safety of deep general anesthesia
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and other institutions supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses.

Released: 10-Jun-2024 10:30 AM EDT
Treating nephrocalcinosis in newborns: A primer for clinicians
UC Davis Health

As many as 40% of preterm infants in the U.S. suffer from nephrocalcinosis, a condition that deposits excess calcium in kidneys.

Newswise: Study links chronic pain to quality of family relationships
Released: 10-Jun-2024 10:05 AM EDT
Study links chronic pain to quality of family relationships
UT Southwestern Medical Center

Strong family relationships have long been associated with a better sense of well-being and connection. Now a team led by UT Southwestern Medical Center researchers has linked the quality of those relationships with how successfully people – particularly aging African Americans – manage pain.

Released: 10-Jun-2024 9:05 AM EDT
FASEB Conferences On-Demand Streams Scientific Breakthroughs
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) launches a new service to stream the latest content from in-person FASEB Science Research Conferences.

   
Released: 10-Jun-2024 9:00 AM EDT
Icahn School of Medicine at Mount Sinai Awarded $21 Million NIH Grant to Advance Understanding of Aging-Related Hormone
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $21 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH), to further advance understanding of an aging-related hormone known as follicle-stimulating hormone (FSH), including its potential role in obesity, osteoporosis, and Alzheimer’s disease.

Released: 10-Jun-2024 9:00 AM EDT
NUTRITION 2024 showcases groundbreaking research on what we eat and why it matters
American Society for Nutrition (ASN)

Be among the first to hear breaking news in food and nutrition science at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition held June 29–July 2 at McCormick Place in Chicago.

Newswise: Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
7-Jun-2024 5:05 PM EDT
Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
University of California, Los Angeles (UCLA), Health Sciences

A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. To date there is no FDA-approved medication for it.

Released: 10-Jun-2024 7:30 AM EDT
Timely response leads to complete recovery for young stroke survivor
Michigan Medicine - University of Michigan

Fewer than 15% of patients make it to a hospital in time to receive the most advanced stroke treatments.

Newswise: Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Released: 10-Jun-2024 7:00 AM EDT
Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 9:00 AM EDT Released to reporters: 9-Jun-2024 8:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 8:00 AM EDT Released to reporters: 9-Jun-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
access_time Embargo lifts in 2 days
This news release is embargoed until 23-Jun-2024 8:00 AM EDT Released to reporters: 9-Jun-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

     
Newswise: Texas Tech Health El Paso, UTEP Announce New MedFuture Cohort, Part of Our Region’s Next Generation of Physicians
Released: 7-Jun-2024 4:30 PM EDT
Texas Tech Health El Paso, UTEP Announce New MedFuture Cohort, Part of Our Region’s Next Generation of Physicians
Texas Tech University Health Sciences Center El Paso

Adolpho and Debbie Telles announce a $50,000 gift for the Adolpho R. and Deborah L. Telles Family Scholarship, which will be matched by the KPMG Foundation to double its impact to $100,000.

Newswise: Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
Released: 7-Jun-2024 12:05 PM EDT
Letter to editor and response: Is neurocysticercosis a main cause of epilepsy?
International League Against Epilepsy

ILAE produced a podcast episode in 2023 in which Dr. Hector Garcia talked about neurocysticercosis as a main cause of epilepsy. Two researchers from Latin America wrote in and questioned how frequently this parasitic infection actually leads to epilepsy. Dr. Garcia responded.

Newswise: Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Released: 7-Jun-2024 11:45 AM EDT
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center - a designation held by less than 4% of cancer centers- awarding Roswell Park the highest possible “Exceptional” rating as it renewed a grant Roswell Park has successfully competed for since 1972.

Newswise: Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Released: 7-Jun-2024 11:00 AM EDT
Fat Molecule’s Inability to Bond with Shape-Shifting Protein in Cell’s Powerhouse Linked to an Inherited Metabolic Disease
Johns Hopkins Medicine

By studying mutations in yeast and human cells, Johns Hopkins Medicine scientists say they have found that biochemical bonds between fats and proteins in the mitochondrion, the cell’s powerhouse, play a crucial role in how our cells produce energy.

Newswise: Reproductive health counseling in young women with epilepsy: Room for improvement
Released: 7-Jun-2024 9:05 AM EDT
Reproductive health counseling in young women with epilepsy: Room for improvement
International League Against Epilepsy

Pediatric neurologists are not counseling young adults with epilepsy about reproductive issues as frequently as needed, according to a recent 10-year study. Some conversations, such as those about pregnancy and the potential effects of antiseizure medications, are almost nonexistent.

Released: 7-Jun-2024 8:05 AM EDT
Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer
Moffitt Cancer Center

Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the first National Cancer Institute-designated comprehensive cancer center with a dedicated bioengineering department. This area of science integrates engineering and physical sciences with oncology to change how we understand and treat this complex disease.

Newswise: Timing key for type 2 diabetes drug performance
Released: 7-Jun-2024 12:05 AM EDT
Timing key for type 2 diabetes drug performance
University of Adelaide

Researchers from the University of Adelaide could be closer to discovering a better way to use metformin, a common type 2 diabetes medication. Metformin, which has been a cornerstone in diabetes treatment since the 1960s, is typically taken with meals to reduce gastrointestinal side effects but new research is suggesting patients could see improved results if it’s taken before meals.

Newswise: Specialist scanning needed to help endo patients
Released: 7-Jun-2024 12:05 AM EDT
Specialist scanning needed to help endo patients
University of Adelaide

A review of existing research shows there is a growing benefit to using specialist scanning to diagnose endometriosis. Endometriosis affects 1 in 9 women and those assigned female at birth. However, it takes 6.4 years to diagnose using the conventional standard of surgical laparoscopy.

Newswise: Dangerous work, unmet health care needs add up to more deaths, negative health outcomes for Texas shrimpers, according to UTHealth Houston research
Released: 6-Jun-2024 4:50 PM EDT
Dangerous work, unmet health care needs add up to more deaths, negative health outcomes for Texas shrimpers, according to UTHealth Houston research
University of Texas Health Science Center at Houston

A dangerous work environment and limited access to health care are related to higher death rates and negative health outcomes among Texas shrimpers in the Gulf of Mexico, according to a new study from UTHealth Houston.

Newswise: UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis
Released: 6-Jun-2024 4:05 PM EDT
UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis
University of Texas at El Paso

Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body’s tissues.

Newswise: High Blood Pressure in the Hospital: What Doctors Should Know
Released: 6-Jun-2024 3:05 PM EDT
High Blood Pressure in the Hospital: What Doctors Should Know
University of Utah Health

A new statement from the American Heart Association recommends a much more conservative approach to treating high blood pressure in acute care.

Released: 6-Jun-2024 3:05 PM EDT
Mayo Clinic: Bioterapias a través del electrospinning del mañana
Mayo Clinic

El futuro de la curación de enfermedades puede involucrar una jeringa, una fuente de alimentación de alto voltaje y soluciones de polímeros que se unen para diseñar tejidos. En este momento, investigadores de Mayo Clinic están estudiando estos diferentes elementos utilizando un electrohilador, un dispositivo que convierte fibras bioterapéuticas en una estructura — o plataforma — para tejer bioterapéuticos regenerativos.

Released: 6-Jun-2024 3:05 PM EDT
Mayo Clinic: Bioterapias via eletrofiação do amanhã
Mayo Clinic

O futuro da cura das doenças pode envolver uma seringa, uma fonte de alimentação de alta tensão e soluções poliméricas que se unem para projetar tecidos. No momento, pesquisadores da Mayo Clinic estão estudando esses diferentes elementos utilizando um eletrofiador, dispositivo que transforma fibras bioterapêuticas em uma estrutura — ou plataforma — para tecer bioterapêuticos regenerativos.

Released: 6-Jun-2024 3:05 PM EDT
مايو كلينك: العلاجات الحيوية المستقبلية المغزولة كهربائيًا
Mayo Clinic

روتشستر، ولاية مينيسوتا - قد يتضمن مستقبل علاج الأمراض استخدام إبرة، ومصدر كهربائي عالي الجهد، ومحاليل بوليمر يلتقون معًا لهندسة الأنسجة. يدرس باحثو مايو كلينك حاليًا هذه العناصر المختلفة باستخدام جهاز غزل كهربائي، وهو جهاز يحوّل الألياف العلاجية الحيوية إلى سقالة - أو قاعدة - لغزل العلاجات الحيوية المتجددة.

Newswise: It’s been 16 Years since sweet-spot brain stimulation slowed Parkinson’s progression for Hermitage man
Released: 6-Jun-2024 3:05 PM EDT
It’s been 16 Years since sweet-spot brain stimulation slowed Parkinson’s progression for Hermitage man
Vanderbilt University Medical Center

In 2008 at VUMC there were a group of doctors trying something unheard of on a handful of patients who signed up for their study. Half would receive deep brain stimulation (DBS) surgery in attempt to slow the progression of their early-stage Parkinson’s disease, and the others would not.

Newswise: discovery_logo.svg
Released: 6-Jun-2024 3:05 PM EDT
ECHO Discovery Webinar: Fish consumption during pregnancy and impacts on child health
Environmental influences on Child Health Outcomes NIH

Three investigators from the Environmental Influences on Child Health Outcomes (ECHO) Program will discuss their recent paper on fish consumption and omega-3 supplementation during pregnancy and recent guidance on fatty acid supplements to prevent preterm birth.

Newswise: Saint Louis University Nursing Professor Honored by National Society for Work in Palliative Care for Children
Released: 6-Jun-2024 2:05 PM EDT
Saint Louis University Nursing Professor Honored by National Society for Work in Palliative Care for Children
Saint Louis University

Verna Hendricks-Ferguson, Ph.D., the Irene Riddle Endowed Chair and professor at the Trudy Busch Valentine School of Nursing at Saint Louis University, was honored with the 2024 Distinguished Researcher Award by the Oncology Nursing Society.

Newswise: 1920_060224-outloudmusicfestival-forpress-danielmacadangdang-8.jpg?10000
Released: 6-Jun-2024 1:05 PM EDT
Cedars-Sinai Designated LGBTQ+ Equality Leader
Cedars-Sinai

Cedars-Sinai has once again earned national recognition as an LGBTQ+ Healthcare Equality Leader.

Newswise: Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
5-Jun-2024 5:05 PM EDT
Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
University of California, Los Angeles (UCLA), Health Sciences

Mpox continues to circulate in the U.S. among gay and bisexual men who have sex with men. Though the number fell sharply to only 3 cases during the June through December 2023 multisite surveillance period compared to the previous highs, concern for its reemergence continues due to, among other things, incomplete knowledge among other groups.

Newswise: Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer
Released: 6-Jun-2024 12:15 PM EDT
Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer
Johns Hopkins Medicine

Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.

Released: 6-Jun-2024 12:05 PM EDT
Minimally invasive blood collection could advance health equity for people experiencing homelessness
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new study demonstrates that minimally invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.

Newswise: 1920_immune-system-cedars-sinai.jpg?10000
Released: 6-Jun-2024 12:05 PM EDT
Cedars-Sinai Investigators Discover Mechanisms of Immunity
Cedars-Sinai

A novel study, led by the Department of Biomedical Sciences at Cedars-Sinai and published today in the peer-reviewed journal Nature, shows how cells use a protein called PD-L1 to rally white blood cells to battle infections.

Released: 6-Jun-2024 12:00 PM EDT
Media Tip Sheet: Honoring the 80th Anniversary of D-Day
George Washington University

World leaders are gathering in Normandy, France, today to honor the 80th anniversary of D-Day. ...

Released: 6-Jun-2024 11:05 AM EDT
Association for Molecular Pathology Publishes Evidence-based Recommendations for Tumor Mutational Burden Testing
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies. These recommendations encompass pre-analytical, analytical, and post-analytical factors of TMB analysis, and emphasize the importance of comprehensive methodological descriptions in publications to allow comparability between assays.



close
0.22788